United States · FDA National Drug Code directory
metronidazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58657-939_51018185-a67f-bf2c-e063-6394a90adca5
- Product NDC
- 58657-939
- Form
- TABLET
- Composition / generic term
- metronidazole
- Labeler
- Method Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250701
- Source listing expiry
- 20271231
Source-listed ingredients
- METRONIDAZOLE — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (58657-939-01) / 1 TABLET in 1 BLISTER PACK (58657-939-10) · 58657-939-01
- 30 BLISTER PACK in 1 CARTON (58657-939-03) / 1 TABLET in 1 BLISTER PACK (58657-939-10) · 58657-939-03
- 50 BLISTER PACK in 1 CARTON (58657-939-05) / 1 TABLET in 1 BLISTER PACK (58657-939-10) · 58657-939-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →